These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38326487)

  • 21. High-dose neuroleptics and neuroleptic rotation for agitated delirium near the end of life.
    Bascom PB; Bordley JL; Lawton AJ
    Am J Hosp Palliat Care; 2014 Dec; 31(8):808-11. PubMed ID: 24081790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: A large-scale multicenter prospective observational study in real-world palliative care settings.
    Maeda I; Ogawa A; Yoshiuchi K; Akechi T; Morita T; Oyamada S; Yamaguchi T; Imai K; Sakashita A; Matsumoto Y; Uemura K; Nakahara R; Iwase S;
    Gen Hosp Psychiatry; 2020; 67():35-41. PubMed ID: 32950826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Objective Measure for Terminal Delirium: Activity Scores Measured by a Sheet-Type Sensor.
    Otani H; Yokomichi N; Imai K; Toyota S; Yamauchi T; Miwa S; Yuasa M; Okamoto S; Kogure T; Inoue S; Morita T
    J Pain Symptom Manage; 2024 Sep; 68(3):246-254. PubMed ID: 38810949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison and agreement between the Richmond Agitation-Sedation Scale and the Riker Sedation-Agitation Scale in evaluating patients' eligibility for delirium assessment in the ICU.
    Khan BA; Guzman O; Campbell NL; Walroth T; Tricker JL; Hui SL; Perkins A; Zawahiri M; Buckley JD; Farber MO; Ely EW; Boustani MA
    Chest; 2012 Jul; 142(1):48-54. PubMed ID: 22539644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of dosing pattern of antipsychotics on treatment outcome of delirium in patients with advanced cancer.
    Abe A; Fujisawa D; Miyajima K; Takeuchi E; Takeuchi M; Mimura M; Imai K; Uemura K; Watanabe H; Matsuo N; Matsuda Y; Maeda I; Ogawa A; Yoshiuchi K; Iwase S
    Jpn J Clin Oncol; 2023 Mar; 53(4):321-326. PubMed ID: 36647601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are common delirium assessment tools appropriate for evaluating delirium at the end of life in cancer patients?
    Uchida M; Morita T; Akechi T; Yokomichi N; Sakashita A; Hisanaga T; Matsui T; Ogawa A; Yoshiuchi K; Iwase S;
    Psychooncology; 2020 Nov; 29(11):1842-1849. PubMed ID: 32735046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
    Boettger S; Jenewein J; Breitbart W
    Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Antipsychotic Dose With Survival of Advanced Cancer Patients With Delirium.
    Yokomichi N; Maeda I; Morita T; Yoshiuchi K; Ogawa A; Hisanaga T; Sakashita A; Nakahara R; Kaneishi K; Iwase S
    J Pain Symptom Manage; 2022 Jul; 64(1):28-36. PubMed ID: 35339614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expert consensus guideline series. Treatment of behavioral emergencies 2005.
    Allen MH; Currier GW; Carpenter D; Ross RW; Docherty JP;
    J Psychiatr Pract; 2005 Nov; 11 Suppl 1():5-108; quiz 110-2. PubMed ID: 16319571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label, parallel-group, randomized controlled trial (DEX-HD trial).
    Minami T; Watanabe H; Kato T; Ikeda K; Ueno K; Matsuyama A; Maeda J; Sakai Y; Harada H; Kuriyama A; Yamaji K; Kitajima N; Kamei J; Takatani Y; Sato Y; Yamashita Y; Mizota T; Ohtsuru S
    BMC Anesthesiol; 2023 Jun; 23(1):193. PubMed ID: 37270483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
    Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
    J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Retrospective Comparison of the Effectiveness and Safety of Intravenous Olanzapine Versus Intravenous Haloperidol for Agitation in Adult Intensive Care Unit Patients.
    Wang M; Yankama TT; Abdallah GT; Eche IJ; Knoph KN; Wong A; Patel P; Hsu D; Eche IM
    J Intensive Care Med; 2022 Feb; 37(2):222-230. PubMed ID: 33426981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients.
    Lacasse H; Perreault MM; Williamson DR
    Ann Pharmacother; 2006 Nov; 40(11):1966-73. PubMed ID: 17047137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dispersion in Scores on the Richmond Agitation and Sedation Scale as a Measure of Delirium in Patients with Subdural Hematomas.
    Robinson D; Thompson S; Bauerschmidt A; Melmed K; Couch C; Park S; Agarwal S; Roh D; Connolly ES; Claassen J
    Neurocrit Care; 2019 Jun; 30(3):626-634. PubMed ID: 30506177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium.
    Grover S; Kumar V; Chakrabarti S
    J Psychosom Res; 2011 Oct; 71(4):277-81. PubMed ID: 21911107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atypical antipsychotic efficacy and safety in managing delirium: a systematic review and critical analysis].
    Pelland C; Trudel JF
    Psychol Neuropsychiatr Vieil; 2009 Jun; 7(2):109-19. PubMed ID: 19473954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detecting Delirium Superimposed on Dementia: Evaluation of the Diagnostic Performance of the Richmond Agitation and Sedation Scale.
    Morandi A; Han JH; Meagher D; Vasilevskis E; Cerejeira J; Hasemann W; MacLullich AM; Annoni G; Trabucchi M; Bellelli G
    J Am Med Dir Assoc; 2016 Sep; 17(9):828-33. PubMed ID: 27346621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department.
    Klein LR; Driver BE; Miner JR; Martel ML; Hessel M; Collins JD; Horton GB; Fagerstrom E; Satpathy R; Cole JB
    Ann Emerg Med; 2018 Oct; 72(4):374-385. PubMed ID: 29885904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.